Dickerson R N, Fried R C, Bailey P M, Stein T P, Mullen J L, Buzby G P
Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia.
J Surg Res. 1990 Jan;48(1):38-41. doi: 10.1016/0022-4804(90)90142-o.
Pharmacologic therapy designed to block adrenergic activity or alter hormonal milieu may modulate energy and protein metabolism in stress. The metabolic effects of propranolol (beta adrenergic receptor blocker) in sepsis was investigated in 22 well-nourished rats that underwent superior vena caval cannulation, cecal ligation, and puncture. Animals were randomly assigned to receive either a continuous infusion of 0.7 mg/day of propranolol combined with parenteral nutrition (n = 11) or parenteral nutrition alone (n = 11). Both groups received isocaloric, isonitrogenous, isovolemic, parenteral nutrition post-operatively for 24 hr. Nitrogen balance was better for the propranolol group than for the control group (+743 +/- 84 mg/kg/day versus +300 +/- 63 mg/kg/day, respectively, P less than 0.05). A significant difference between the pharmacologic therapy and control groups was noted for urinary 3-methylhistidine excretion versus control (0.99 +/- 0.08 micrograms/kg/day versus 7.5 +/- 0.37 micrograms/kg/day, respectively, P less than 0.01). Measured energy expenditure was similar for both pharmacologic therapy and control groups (149 +/- 20 kcal/kg/day versus 134 +/- 11 kcal/kg/day, respectively, P = N.S.). No statistically significant difference was demonstrated for 24-hr survival between propranolol and control groups (73 and 64%, respectively). Continuous, low-dose propranolol promotes nitrogen retention and decreases 3-methylhistidine excretion without altering energy expenditure in parenterally fed septic rats.
旨在阻断肾上腺素能活性或改变激素环境的药物治疗可能会调节应激状态下的能量和蛋白质代谢。在22只营养良好的大鼠身上进行了研究,这些大鼠接受了上腔静脉插管、盲肠结扎和穿刺手术,以探究普萘洛尔(β肾上腺素能受体阻滞剂)在脓毒症中的代谢作用。动物被随机分为两组,一组连续输注0.7毫克/天的普萘洛尔并联合肠外营养(n = 11),另一组仅接受肠外营养(n = 11)。两组术后均接受等热量、等氮量、等容量的肠外营养24小时。普萘洛尔组的氮平衡优于对照组(分别为+743±84毫克/千克/天和+300±63毫克/千克/天,P<0.05)。药物治疗组和对照组在尿3-甲基组氨酸排泄方面存在显著差异(分别为0.99±0.08微克/千克/天和7.5±0.37微克/千克/天,P<0.01)。药物治疗组和对照组的实测能量消耗相似(分别为149±20千卡/千克/天和134±11千卡/千克/天,P =无显著性差异)。普萘洛尔组和对照组在24小时生存率方面无统计学显著差异(分别为73%和64%)。连续低剂量普萘洛尔可促进氮潴留并减少3-甲基组氨酸排泄,而不改变肠外营养的脓毒症大鼠的能量消耗。